About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-TI
A4263G
A4263G-F1
A4263G-F2
A4267G
A4269G
A4279G
A4281G
A4295G
A4295G-F4
A4295G-F3
A4295G-F2
A4295G-F1
A4300G
A4300G-F4
A4300G-F3
A4300G-F2
A4300G-F1
A4302G
A4316G
A4316G-F1
A4317G
A4317G-F5
A4317G-F4
A4317G-F3
C4320T
G4282A
G4284A
G4284A-F2
G4284A-F1
G4296A
G4296A-F4
G4296A-F3
G4296A-F2
G4296A-F1
G4298A
G4298A-F2
G4298A-F1
G4308A
G4309A
G4309A-F2
T4268C
T4268C-F1
T4274C
T4277C
T4277C-F1
T4285C
T4289C
T4289C-F1
T4290C
T4290C-F1
T4291C
T4291C-F2
T4291C-F1
T4327C
Edit by Mitofam Team
-
+
首页
A4263G-F1
**Figure 1\. Pedigree diagram for family A4263G\-F1\.**  # Pedigree Information | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 4263 | m.4263A\>G | A4263G\-F1 | China | Essential hypertension | 11 | 14 | 2011 | [21454794](https://pubmed.ncbi.nlm.nih.gov/21454794/) | | The **m.4263A\>G** variant in MT\-TI was reported in family A4263G\-F1 from China with essential hypertension. The pedigree record reported 11 unaffected and 14 affected maternal relatives, and the carrier table includes 27 listed carriers. Homoplasmy was reported in all listed carriers; 15/27 carriers were affected, and the main clinical manifestation among affected carriers was essential hypertension. # Carrier Information | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-I2 | Uninf | F | N | Y | D | ND | Homo | / | / | / | Essential hypertension | | | 2 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-II2 | Fam | F | N | Y | A | 79 | Homo | / | / | / | Essential hypertension | | | 3 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-II4 | Fam | F | N | Y | A | 72 | Homo | / | / | / | Essential hypertension | | | 4 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-II5 | Fam | M | N | Y | A | 82 | Homo | / | / | / | Essential hypertension | | | 5 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-II7 | Fam | M | N | Y | A | 68 | Homo | / | / | / | Essential hypertension | | | 6 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III2 | Fam | F | N | Y | A | 54 | Homo | / | / | / | Essential hypertension | | | 7 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III4 | Fam | F | N | Y | A | 48 | Homo | / | / | / | Essential hypertension | | | 8 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III5 | Fam | M | N | N | A | 42 | Homo | / | / | / | Healthy | | | 9 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III7 | Fam | M | N | N | A | 44 | Homo | / | / | / | Healthy | | | 10 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III9 | Fam | M | N | Y | A | 40 | Homo | / | / | / | Essential hypertension | | | 11 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III11 | Fam | M | N | Y | A | 56 | Homo | / | / | / | Essential hypertension | | | 12 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III14 | Fam | F | Y | Y | A | 48 | Homo | / | / | / | Essential hypertension | | | 13 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III16 | Fam | F | N | N | A | 45 | Homo | / | / | / | Healthy | | | 14 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III18 | Fam | F | N | Y | A | 52 | Homo | / | / | / | Essential hypertension | | | 15 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-III19 | Fam | M | N | N | A | 33 | Homo | / | / | / | Healthy | | | 16 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-IV1 | Fam | F | N | Y | A | 31 | Homo | / | / | / | Essential hypertension | | | 17 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-IV3 | Fam | F | N | Y | A | 26 | Homo | / | / | / | Essential hypertension | | | 18 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-IV5 | Fam | M | N | Y | A | 25 | Homo | / | / | / | Essential hypertension | | | 19 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-IV6 | Fam | M | N | N | A | 24 | Homo | / | / | / | Healthy | | | 20 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-IV7 | Fam | M | N | Y | A | 23 | Homo | / | / | / | Essential hypertension | | | 21 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-IV8 | Fam | F | N | N | A | 21 | Homo | / | / | / | Healthy | | | 22 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-IV21 | Fam | F | N | N | A | 24 | Homo | / | / | / | Healthy | | | 23 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-IV22 | Fam | F | N | N | A | 18 | Homo | / | / | / | Healthy | | | 24 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-IV23 | Fam | M | N | N | A | 25 | Homo | / | / | / | Healthy | | | 25 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-V1 | Fam | M | N | N | A | 5 | Homo | / | / | / | Healthy | | | 26 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-V2 | Fam | M | N | N | A | 6 | Homo | / | / | / | Healthy | | | 27 | 4263 | m.4263A\>G | A4263G\-F1 | A4263G\-F1\-V3 | Fam | F | N | N | A | 4 | Homo | / | / | / | Healthy | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年7月1日 02:30
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)